A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging

Human sarcomas are rare but diverse malignant tumors derived from mesenchymal tissue. Clinical response to therapy is currently determined by the modified World Health Organization (WHO) criteria or the Response Evaluation Criteria in Solid Tumors (RECIST), but these standards correlate poorly with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hajitou, Amin, Lev, Dina C., Hannay, Jonathan A. F., Korchin, Borys, Staquicini, Fernanda I., Soghomonyan, Suren, Alauddin, Mian M., Benjamin, Robert S., Pollock, Raphael E., Gelovani, Juri G., Pasqualini, Renata, Arap, Wadih
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2008
Materias:
Biological Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2393798/
https://ncbi.nlm.nih.gov/pubmed/18337507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0712184105
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares